✦ LIBER ✦

Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma

✍ Scribed by Benedetto Bruno; Roberto Sorasio; Francesca Patriarca; Vittorio Montefusco; Stefano Guidi; Alessandro Busca; Rosanna Scimé; Giuseppe Console; Giuseppe Milone; Giuseppe Marotta; Alida Dominietto; Luisa Giaccone; Marcello Rotta; Michele Falda; Andrea Bacigalupo; Alberto Bosi; Paolo Corradini; Renato Fanin; Simona Pollichieni; Mario Boccadoro; Gruppo Italiano Trapianto Midollo Osseo (GITMO)

Book ID: 114794150
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 518 KB
Volume: 78
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2007.00816.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unrelated donor hematopoietic cell trans

✍ G.E. Georges; M.B. Maris; B.M. Sandmaier; M.J. Stuart; D. Niederwieser; E. Agura 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Comparable outcomes between unrelated an

Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma

✍ Jean El-Cheikh; Roberto Crocchiolo; Jean-Marie Boher; Sabine Furst; Anne-Marie S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Lenalidomide plus donor-lymphocytes infu

Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma

✍ Jean El-Cheikh; Roberto Crocchiolo; Sabine Furst; Patrick Ladaique; Luca Castagn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Prognostic factors in allogeneic transpl

Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning

✍ Choon-Kee Lee; Ashraf Badros; Bart Barlogie; Christopher Morris; Maurizio Zangar 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Nonmyeloablative Unrelated Donor Hematop

Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation to Treat Patients with Poor-Risk, Relapsed, or Refractory Multiple Myeloma

✍ George E. Georges; Michael B. Maris; David G. Maloney; Brenda M. Sandmaier; Moha 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 188 KB

196Non-Myeloablative Stem Cell Transplan

196Non-Myeloablative Stem Cell Transplantation (SCT) is safe and effective for patients with multiple myeloma

✍ J.S. Moreb; C.R. Cogle; H.L. Leather; L. Wiggins; K.J. Finiewicz; S.A. Khan; V.S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 148 KB